Rapid colorimetric polymyxin B microelution directly from positive blood bottles: because patients with serious infections should not have to wait for results of culture-based methodologies-Reference-Cited by-同舟云学术

Rapid colorimetric polymyxin B microelution directly from positive blood bottles: because patients with serious infections should not have to wait for results of culture-based methodologies

Published:2024-05-11 Issue:7 Volume:43 Page:1407-1417
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Collar Gabriela da Silva^ORCID,Becker Julia,Moreira Natália Kehl,Dornelles Luana Silva,Mott Mariana Preussler,Barth Afonso Luís,Caierão Juliana^ORCID

Funder

Fundo de Incentivo à Pesquisa e Eventos from Hospital de Clínicas de Porto Alegre – FIPE/ HCPA

Instituto Nacional de Pesquisa em Resistência Antimicrobiana – INPRA

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10096-024-04846-3.pdf

Reference27 articles.

1. Xu L, Sun X, Ma X (2017) Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob 16(1):18. https://doi.org/10.1186/s12941-017-0191-3

2. Tsuji BT, Pogue JM, Zavascki AP et al (2019) International Consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for anti-infective pharmacology (ISAP), society of critical Care Medicine (SCCM), and Society of Infectious diseases pharmacists (SIDP). Pharmacother J Hum Pharmacol Drug Ther 39(1):10–39. https://doi.org/10.1002/phar.2209

3. Zeng M, Xia J, Zong Z, Shi Y et al (2023) Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect 56(4):653–671. https://doi.org/10.1016/j.jmii.2023.01.017

4. Paul M, Carrara E, Retamar P et al (2022) European Society of Clinical Microbiology and Infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 28(4):521–547. https://doi.org/10.1016/j.cmi.2021.11.025

5. Soman R, Bakthavatchalam YD, Nadarajan A et al (2021) Is it time to move away from polymyxins? Evidence and alternatives. Eur J Clin Microbiol Infect Dis 40(3):461–475. https://doi.org/10.1007/s10096-020-04053-w